ICU MEDICAL INC (ICUI) Stock Fundamental Analysis

NASDAQ:ICUI • US44930G1076

142.66 USD
-4.33 (-2.95%)
At close: Mar 3, 2026
142.66 USD
0 (0%)
After Hours: 3/3/2026, 8:18:43 PM
Fundamental Rating

4

ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • In the past year ICUI had a positive cash flow from operations.
  • In the past 5 years ICUI reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ICUI reported negative operating cash flow in multiple years.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of ICUI (-0.18%) is better than 72.28% of its industry peers.
  • The Return On Equity of ICUI (-0.35%) is better than 72.83% of its industry peers.
  • The Return On Invested Capital of ICUI (2.86%) is better than 70.11% of its industry peers.
  • ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.75%.
  • The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROIC 2.86%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ICUI has a Operating Margin of 5.63%. This is in the better half of the industry: ICUI outperforms 70.11% of its industry peers.
  • In the last couple of years the Operating Margin of ICUI has declined.
  • ICUI has a worse Gross Margin (36.47%) than 71.74% of its industry peers.
  • In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
Industry RankSector Rank
OM 5.63%
PM (TTM) N/A
GM 36.47%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
  • There is no outstanding debt for ICUI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ICUI has an Altman-Z score of 2.22. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ICUI has a better Altman-Z score (2.22) than 63.04% of its industry peers.
  • ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 21.21, ICUI is in the better half of the industry, outperforming 68.48% of the companies in the same industry.
  • ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ICUI (0.62) is worse than 64.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Altman-Z 2.22
ROIC/WACC0.29
WACC9.86%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
  • ICUI's Current ratio of 2.45 is in line compared to the rest of the industry. ICUI outperforms 48.91% of its industry peers.
  • ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
  • ICUI has a worse Quick ratio (1.19) than 67.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.19
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.76% over the past year.
  • The Earnings Per Share has been growing slightly by 1.71% on average over the past years.
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.78%

3.2 Future

  • ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.14% yearly.
  • The Revenue is expected to grow by 5.02% on average over the next years.
EPS Next Y5.7%
EPS Next 2Y10.39%
EPS Next 3Y15.46%
EPS Next 5Y12.14%
Revenue Next Year-2.36%
Revenue Next 2Y0.82%
Revenue Next 3Y5.53%
Revenue Next 5Y5.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.38, ICUI is valued on the expensive side.
  • Based on the Price/Earnings ratio, ICUI is valued cheaper than 83.70% of the companies in the same industry.
  • ICUI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.83.
  • Based on the Price/Forward Earnings ratio of 17.39, the valuation of ICUI can be described as rather expensive.
  • ICUI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 84.24% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ICUI to the average of the S&P500 Index (24.95), we can say ICUI is valued slightly cheaper.
Industry RankSector Rank
PE 18.38
Fwd PE 17.39
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 84.78% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than 70.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.6
EV/EBITDA 13.94
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.46% in the coming years.
PEG (NY)3.22
PEG (5Y)10.76
EPS Next 2Y10.39%
EPS Next 3Y15.46%

0

5. Dividend

5.1 Amount

  • No dividends for ICUI!.
Industry RankSector Rank
Dividend Yield 0%

ICU MEDICAL INC

NASDAQ:ICUI (3/3/2026, 8:18:43 PM)

After market: 142.66 0 (0%)

142.66

-4.33 (-2.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners118.03%
Inst Owner Change-1.88%
Ins Owners0.96%
Ins Owner Change-2.94%
Market Cap3.52B
Revenue(TTM)N/A
Net Income(TTM)-7.36M
Analysts83.33
Price Target187.27 (31.27%)
Short Float %4.25%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.43%
Revenue beat(4)3
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)6
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)1.21%
PT rev (3m)1.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)7.65%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 18.38
Fwd PE 17.39
P/S 1.52
P/FCF 56.6
P/OCF 22.09
P/B 1.66
P/tB N/A
EV/EBITDA 13.94
EPS(TTM)7.76
EY5.44%
EPS(NY)8.2
Fwd EY5.75%
FCF(TTM)2.52
FCFY1.77%
OCF(TTM)6.46
OCFY4.53%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)3.22
PEG (5Y)10.76
Graham Number122.65
Profitability
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROCE 3.62%
ROIC 2.86%
ROICexc 3.12%
ROICexgc 9.01%
OM 5.63%
PM (TTM) N/A
GM 36.47%
FCFM 2.68%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Debt/EBITDA 3.95
Cap/Depr 47.91%
Cap/Sales 4.19%
Interest Coverage 250
Cash Conversion 47.79%
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 1.19
Altman-Z 2.22
F-Score7
WACC9.86%
ROIC/WACC0.29
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
EPS Next Y5.7%
EPS Next 2Y10.39%
EPS Next 3Y15.46%
EPS Next 5Y12.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.78%
Revenue Next Year-2.36%
Revenue Next 2Y0.82%
Revenue Next 3Y5.53%
Revenue Next 5Y5.02%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y17.62%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%

ICU MEDICAL INC / ICUI FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 5.7% in the next year.